Dofetilide (Mayne Pharma Inc.)
Welcome to the PulseAid listing for the Dofetilide drug offered from Mayne Pharma Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mayne Pharma Inc. |
NON-PROPRIETARY NAME: | Dofetilide |
SUBSTANCE NAME: | DOFETILIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-06-07 |
END MARKETING DATE: | 0000-00-00 |
Dofetilide HUMAN PRESCRIPTION DRUG Details:
Item Description | Dofetilide from Mayne Pharma Inc. |
LABELER NAME: | Mayne Pharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2016-06-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51862-005_9ef855ed-9897-4d05-9490-29a004a2e026 |
PRODUCT NDC: | 51862-005 |
APPLICATION NUMBER: | ANDA207058 |
Other DOFETILIDE Pharmaceutical Manufacturers / Labelers: